Denosumab in bone marrow oedema syndrome

Injury. 2017 Jun;48(6):1275-1276. doi: 10.1016/j.injury.2017.04.005. Epub 2017 Apr 13.

Authors

Lars Grøvle¹, Anne Julsrud Haugen²

Affiliations

¹ Department of Rheumatology, Østfold Hospital Trust, 1714 Grålum, Norway. Electronic address: lars.grovle@so-hf.no.
² Department of Rheumatology, Østfold Hospital Trust, 1714 Grålum, Norway.

PMID: 28431819
DOI: 10.1016/j.injury.2017.04.005

No abstract available

Publication types

Letter
Comment

MeSH terms

Bone Density Conservation Agents
Bone Marrow Diseases
Bone Marrow*
Denosumab*
Edema
Humans
RANK Ligand
Syndrome

Substances

Bone Density Conservation Agents
RANK Ligand
Denosumab